Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Us...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mi‐Hyang Jung, Dong‐Hyuk Cho, Jimi Choi, Mi‐Na Kim, Chan Joo Lee, Jung‐Woo Son, Yaeni Kim, Jong‐Chan Youn, Byung‐Su Yoo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Oxford University Press 2025-10-01
Edice:	ESC Heart Failure
Témata:	Heart failure, systolic Hospitalization Kidney failure, chronic Mortality Renin‐angiotensin system Treatment outcome
On-line přístup:	https://doi.org/10.1002/ehf2.15359
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!